▶ 調査レポート

医薬品有効成分(API)の世界市場:市場規模・現状・予測

• 英文タイトル:Global Active Pharmaceutical Ingredient (API) Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。医薬品有効成分(API)の世界市場:市場規模・現状・予測 / Global Active Pharmaceutical Ingredient (API) Market Size, Status and Forecast 2019-2025 / QYR9ST04684資料のイメージです。• レポートコード:QYR9ST04684
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、91ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、医薬品有効成分(API)の世界市場について調査・分析し、医薬品有効成分(API)の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(革新的APISセグメント、汎用APISセグメント)、用途別(腫瘍学、糖尿病、循環器疾患、中枢神経系及び神経障害、整形外科疾患、腎臓病学、眼科、呼吸器、胃腸障害、内分泌学)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の医薬品有効成分(API)市場動向
・主要企業別マーケットシェア
・医薬品有効成分(API)の種類別市場規模2014-2019
(革新的APISセグメント、汎用APISセグメント)
・医薬品有効成分(API)の用途別市場規模2014-2019
(腫瘍学、糖尿病、循環器疾患、中枢神経系及び神経障害、整形外科疾患、腎臓病学、眼科、呼吸器、胃腸障害、内分泌学)
・医薬品有効成分(API)の北米市場:主要企業・種類別/用途別市場規模
・医薬品有効成分(API)のヨーロッパ市場:主要企業・種類別/用途別市場規模
・医薬品有効成分(API)の中国市場:主要企業・種類別/用途別市場規模
・医薬品有効成分(API)の日本国内市場:主要企業・種類別/用途別市場規模
・医薬品有効成分(API)の東南アジア市場:主要企業・種類別/用途別市場規模
・医薬品有効成分(API)のインド市場:主要企業・種類別/用途別市場規模
・医薬品有効成分(API)の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Teva、Sun Pharmaceutical、Aurobindo Pharma、Albemarle、Sigma-Aldrich、Mylan、Allergan)
・医薬品有効成分(API)の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.In 2018, the global Active Pharmaceutical Ingredient (API) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Active Pharmaceutical Ingredient (API) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Active Pharmaceutical Ingredient (API) development in United States, Europe and China.

The key players covered in this study
Teva
Sun Pharmaceutical
Aurobindo Pharma
Albemarle
Sigma-Aldrich
Mylan
Allergan

Market segment by Type, the product can be split into
Innovative APIS Segment
Generic APIS Segment

Market segment by Application, split into
Oncology
Diabetes
Cardiovascular Disease
Cns and Neurological Disorders
Orthopedic Disorders
Nephrology
Ophthalmology
Pulmonology
Gastrointestinal Disorders
Endocrinology

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Active Pharmaceutical Ingredient (API) status, future forecast, growth opportunity, key market and key players.
To present the Active Pharmaceutical Ingredient (API) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Active Pharmaceutical Ingredient (API) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Active Pharmaceutical Ingredient (API) Market Size Growth Rate by Type (2014-2025)
1.4.2 Innovative APIS Segment
1.4.3 Generic APIS Segment
1.5 Market by Application
1.5.1 Global Active Pharmaceutical Ingredient (API) Market Share by Application (2014-2025)
1.5.2 Oncology
1.5.3 Diabetes
1.5.4 Cardiovascular Disease
1.5.5 Cns and Neurological Disorders
1.5.6 Orthopedic Disorders
1.5.7 Nephrology
1.5.8 Ophthalmology
1.5.9 Pulmonology
1.5.10 Gastrointestinal Disorders
1.5.11 Endocrinology
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Active Pharmaceutical Ingredient (API) Market Size
2.2 Active Pharmaceutical Ingredient (API) Growth Trends by Regions
2.2.1 Active Pharmaceutical Ingredient (API) Market Size by Regions (2014-2025)
2.2.2 Active Pharmaceutical Ingredient (API) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Active Pharmaceutical Ingredient (API) Market Size by Manufacturers
3.1.1 Global Active Pharmaceutical Ingredient (API) Revenue by Manufacturers (2014-2019)
3.1.2 Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Active Pharmaceutical Ingredient (API) Market Concentration Ratio (CR5 and HHI)
3.2 Active Pharmaceutical Ingredient (API) Key Players Head office and Area Served
3.3 Key Players Active Pharmaceutical Ingredient (API) Product/Solution/Service
3.4 Date of Enter into Active Pharmaceutical Ingredient (API) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Active Pharmaceutical Ingredient (API) Market Size by Type (2014-2019)
4.2 Global Active Pharmaceutical Ingredient (API) Market Size by Application (2014-2019)

5 United States
5.1 United States Active Pharmaceutical Ingredient (API) Market Size (2014-2019)
5.2 Active Pharmaceutical Ingredient (API) Key Players in United States
5.3 United States Active Pharmaceutical Ingredient (API) Market Size by Type
5.4 United States Active Pharmaceutical Ingredient (API) Market Size by Application

6 Europe
6.1 Europe Active Pharmaceutical Ingredient (API) Market Size (2014-2019)
6.2 Active Pharmaceutical Ingredient (API) Key Players in Europe
6.3 Europe Active Pharmaceutical Ingredient (API) Market Size by Type
6.4 Europe Active Pharmaceutical Ingredient (API) Market Size by Application

7 China
7.1 China Active Pharmaceutical Ingredient (API) Market Size (2014-2019)
7.2 Active Pharmaceutical Ingredient (API) Key Players in China
7.3 China Active Pharmaceutical Ingredient (API) Market Size by Type
7.4 China Active Pharmaceutical Ingredient (API) Market Size by Application

8 Japan
8.1 Japan Active Pharmaceutical Ingredient (API) Market Size (2014-2019)
8.2 Active Pharmaceutical Ingredient (API) Key Players in Japan
8.3 Japan Active Pharmaceutical Ingredient (API) Market Size by Type
8.4 Japan Active Pharmaceutical Ingredient (API) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Active Pharmaceutical Ingredient (API) Market Size (2014-2019)
9.2 Active Pharmaceutical Ingredient (API) Key Players in Southeast Asia
9.3 Southeast Asia Active Pharmaceutical Ingredient (API) Market Size by Type
9.4 Southeast Asia Active Pharmaceutical Ingredient (API) Market Size by Application

10 India
10.1 India Active Pharmaceutical Ingredient (API) Market Size (2014-2019)
10.2 Active Pharmaceutical Ingredient (API) Key Players in India
10.3 India Active Pharmaceutical Ingredient (API) Market Size by Type
10.4 India Active Pharmaceutical Ingredient (API) Market Size by Application

11 Central & South America
11.1 Central & South America Active Pharmaceutical Ingredient (API) Market Size (2014-2019)
11.2 Active Pharmaceutical Ingredient (API) Key Players in Central & South America
11.3 Central & South America Active Pharmaceutical Ingredient (API) Market Size by Type
11.4 Central & South America Active Pharmaceutical Ingredient (API) Market Size by Application

12 International Players Profiles
12.1 Teva
12.1.1 Teva Company Details
12.1.2 Company Description and Business Overview
12.1.3 Active Pharmaceutical Ingredient (API) Introduction
12.1.4 Teva Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)
12.1.5 Teva Recent Development
12.2 Sun Pharmaceutical
12.2.1 Sun Pharmaceutical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Active Pharmaceutical Ingredient (API) Introduction
12.2.4 Sun Pharmaceutical Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)
12.2.5 Sun Pharmaceutical Recent Development
12.3 Aurobindo Pharma
12.3.1 Aurobindo Pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Active Pharmaceutical Ingredient (API) Introduction
12.3.4 Aurobindo Pharma Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)
12.3.5 Aurobindo Pharma Recent Development
12.4 Albemarle
12.4.1 Albemarle Company Details
12.4.2 Company Description and Business Overview
12.4.3 Active Pharmaceutical Ingredient (API) Introduction
12.4.4 Albemarle Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)
12.4.5 Albemarle Recent Development
12.5 Sigma-Aldrich
12.5.1 Sigma-Aldrich Company Details
12.5.2 Company Description and Business Overview
12.5.3 Active Pharmaceutical Ingredient (API) Introduction
12.5.4 Sigma-Aldrich Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)
12.5.5 Sigma-Aldrich Recent Development
12.6 Mylan
12.6.1 Mylan Company Details
12.6.2 Company Description and Business Overview
12.6.3 Active Pharmaceutical Ingredient (API) Introduction
12.6.4 Mylan Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)
12.6.5 Mylan Recent Development
12.7 Allergan
12.7.1 Allergan Company Details
12.7.2 Company Description and Business Overview
12.7.3 Active Pharmaceutical Ingredient (API) Introduction
12.7.4 Allergan Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)
12.7.5 Allergan Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Active Pharmaceutical Ingredient (API) Key Market Segments
Table Key Players Active Pharmaceutical Ingredient (API) Covered
Table Global Active Pharmaceutical Ingredient (API) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Active Pharmaceutical Ingredient (API) Market Size Market Share by Type 2014-2025
Figure Innovative APIS Segment Figures
Table Key Players of Innovative APIS Segment
Figure Generic APIS Segment Figures
Table Key Players of Generic APIS Segment
Table Global Active Pharmaceutical Ingredient (API) Market Size Growth by Application 2014-2025 (Million US$)
Figure Oncology Case Studies
Figure Diabetes Case Studies
Figure Cardiovascular Disease Case Studies
Figure Cns and Neurological Disorders Case Studies
Figure Orthopedic Disorders Case Studies
Figure Nephrology Case Studies
Figure Ophthalmology Case Studies
Figure Pulmonology Case Studies
Figure Gastrointestinal Disorders Case Studies
Figure Endocrinology Case Studies
Figure Active Pharmaceutical Ingredient (API) Report Years Considered
Table Global Active Pharmaceutical Ingredient (API) Market Size 2014-2025 (Million US$)
Figure Global Active Pharmaceutical Ingredient (API) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Active Pharmaceutical Ingredient (API) Market Size by Regions 2014-2025 (Million US$)
Table Global Active Pharmaceutical Ingredient (API) Market Size by Regions 2014-2019 (Million US$)
Table Global Active Pharmaceutical Ingredient (API) Market Share by Regions 2014-2019
Figure Global Active Pharmaceutical Ingredient (API) Market Share by Regions 2014-2019
Figure Global Active Pharmaceutical Ingredient (API) Market Share by Regions 2019
Table Market Top Trends
Table Global Active Pharmaceutical Ingredient (API) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Active Pharmaceutical Ingredient (API) Market Share by Manufacturers (2014-2019)
Figure Global Active Pharmaceutical Ingredient (API) Market Share by Manufacturers in 2018
Table Global Active Pharmaceutical Ingredient (API) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Active Pharmaceutical Ingredient (API) Product/Solution/Service
Table Date of Enter into Active Pharmaceutical Ingredient (API) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Active Pharmaceutical Ingredient (API) Market Size by Type (2014-2019) (Million US$)
Table Global Active Pharmaceutical Ingredient (API) Market Size Share by Type (2014-2019)
Figure Global Active Pharmaceutical Ingredient (API) Market Size Market Share by Type (2014-2019)
Table Global Active Pharmaceutical Ingredient (API) Market Size by Application (2014-2019) (Million US$)
Table Global Active Pharmaceutical Ingredient (API) Market Size Share by Application (2014-2019)
Figure Global Active Pharmaceutical Ingredient (API) Market Size Market Share by Application (2014-2019)
Figure Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Application in 2018
Figure United States Active Pharmaceutical Ingredient (API) Market Size 2014-2019 (Million US$)
Table United States Key Players Active Pharmaceutical Ingredient (API) Revenue (2018-2019) (Million US$)
Table United States Key Players Active Pharmaceutical Ingredient (API) Market Share (2018-2019)
Table United States Active Pharmaceutical Ingredient (API) Market Size by Type (2014-2019) (Million US$)
Table United States Active Pharmaceutical Ingredient (API) Market Share by Type (2014-2019)
Table United States Active Pharmaceutical Ingredient (API) Market Size by Application (2014-2019) (Million US$)
Table United States Active Pharmaceutical Ingredient (API) Market Share by Application (2014-2019)
Figure Europe Active Pharmaceutical Ingredient (API) Market Size 2014-2019 (Million US$)
Table Europe Key Players Active Pharmaceutical Ingredient (API) Revenue (2018-2019) (Million US$)
Table Europe Key Players Active Pharmaceutical Ingredient (API) Market Share (2018-2019)
Table Europe Active Pharmaceutical Ingredient (API) Market Size by Type (2014-2019) (Million US$)
Table Europe Active Pharmaceutical Ingredient (API) Market Share by Type (2014-2019)
Table Europe Active Pharmaceutical Ingredient (API) Market Size by Application (2014-2019) (Million US$)
Table Europe Active Pharmaceutical Ingredient (API) Market Share by Application (2014-2019)
Figure China Active Pharmaceutical Ingredient (API) Market Size 2014-2019 (Million US$)
Table China Key Players Active Pharmaceutical Ingredient (API) Revenue (2018-2019) (Million US$)
Table China Key Players Active Pharmaceutical Ingredient (API) Market Share (2018-2019)
Table China Active Pharmaceutical Ingredient (API) Market Size by Type (2014-20189) (Million US$)
Table China Active Pharmaceutical Ingredient (API) Market Share by Type (2014-2019)
Table China Active Pharmaceutical Ingredient (API) Market Size by Application (2014-2019) (Million US$)
Table China Active Pharmaceutical Ingredient (API) Market Share by Application (2014-2019)
Figure Japan Active Pharmaceutical Ingredient (API) Market Size 2014-2019 (Million US$)
Table Japan Key Players Active Pharmaceutical Ingredient (API) Revenue (2018-2019) (Million US$)
Table Japan Key Players Active Pharmaceutical Ingredient (API) Market Share (2018-2019)
Table Japan Active Pharmaceutical Ingredient (API) Market Size by Type (2014-2019) (Million US$)
Table Japan Active Pharmaceutical Ingredient (API) Market Share by Type (2014-2019)
Table Japan Active Pharmaceutical Ingredient (API) Market Size by Application (2014-2019) (Million US$)
Table Japan Active Pharmaceutical Ingredient (API) Market Share by Application (2014-2019)
Figure Southeast Asia Active Pharmaceutical Ingredient (API) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Active Pharmaceutical Ingredient (API) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Active Pharmaceutical Ingredient (API) Market Share (2018-2019)
Table Southeast Asia Active Pharmaceutical Ingredient (API) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Active Pharmaceutical Ingredient (API) Market Share by Type (2014-2019)
Table Southeast Asia Active Pharmaceutical Ingredient (API) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Active Pharmaceutical Ingredient (API) Market Share by Application (2014-2019)
Figure India Active Pharmaceutical Ingredient (API) Market Size 2014-2019 (Million US$)
Table India Key Players Active Pharmaceutical Ingredient (API) Revenue (2018-2019) (Million US$)
Table India Key Players Active Pharmaceutical Ingredient (API) Market Share (2018-2019)
Table India Active Pharmaceutical Ingredient (API) Market Size by Type (2014-2019) (Million US$)
Table India Active Pharmaceutical Ingredient (API) Market Share by Type (2014-2019)
Table India Active Pharmaceutical Ingredient (API) Market Size by Application (2014-2019) (Million US$)
Table India Active Pharmaceutical Ingredient (API) Market Share by Application (2014-2019)
Figure Central & South America Active Pharmaceutical Ingredient (API) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Active Pharmaceutical Ingredient (API) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Active Pharmaceutical Ingredient (API) Market Share (2018-2019)
Table Central & South America Active Pharmaceutical Ingredient (API) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Active Pharmaceutical Ingredient (API) Market Share by Type (2014-2019)
Table Central & South America Active Pharmaceutical Ingredient (API) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Active Pharmaceutical Ingredient (API) Market Share by Application (2014-2019)
Table Teva Company Details
Table Teva Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019) (Million US$)
Figure Teva Revenue Growth Rate in Active Pharmaceutical Ingredient (API) Business (2014-2019)
Table Teva Recent Development
Table Sun Pharmaceutical Company Details
Table Sun Pharmaceutical Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)(Million US$)
Figure Sun Pharmaceutical Revenue Growth Rate in Active Pharmaceutical Ingredient (API) Business (2014-2019)
Table Sun Pharmaceutical Recent Development
Table Aurobindo Pharma Company Details
Table Aurobindo Pharma Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)(Million US$)
Figure Aurobindo Pharma Revenue Growth Rate in Active Pharmaceutical Ingredient (API) Business (2014-2019)
Table Aurobindo Pharma Recent Development
Table Albemarle Company Details
Table Albemarle Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)(Million US$)
Figure Albemarle Revenue Growth Rate in Active Pharmaceutical Ingredient (API) Business (2014-2019)
Table Albemarle Recent Development
Table Sigma-Aldrich Company Details
Table Sigma-Aldrich Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)(Million US$)
Figure Sigma-Aldrich Revenue Growth Rate in Active Pharmaceutical Ingredient (API) Business (2014-2019)
Table Sigma-Aldrich Recent Development
Table Mylan Company Details
Table Mylan Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Active Pharmaceutical Ingredient (API) Business (2014-2019)
Table Mylan Recent Development
Table Allergan Company Details
Table Allergan Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Active Pharmaceutical Ingredient (API) Business (2014-2019)
Table Allergan Recent Development
Table Global Active Pharmaceutical Ingredient (API) Market Size by Regions (Million US$) 2019-2025
Figure Global Active Pharmaceutical Ingredient (API) Market Size Share by Regions (2019-2025)
Figure Global Active Pharmaceutical Ingredient (API) Market Size Share by Regions in 2025
Figure United States Active Pharmaceutical Ingredient (API) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Active Pharmaceutical Ingredient (API) Market Size Forecast (2019-2025)(Million USD)
Figure China Active Pharmaceutical Ingredient (API) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Active Pharmaceutical Ingredient (API) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Active Pharmaceutical Ingredient (API) Market Size Forecast (2019-2025)(Million USD)
Figure India Active Pharmaceutical Ingredient (API) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Active Pharmaceutical Ingredient (API) Market Size Forecast (2019-2025)(Million USD)
Table Global Active Pharmaceutical Ingredient (API) Market Size by Product (2019-2025) (Million US$)
Figure Global Active Pharmaceutical Ingredient (API) Market Size by Product (2019-2025)
Figure Global Active Pharmaceutical Ingredient (API) Market Size by Product in 2025
Table Global Active Pharmaceutical Ingredient (API) Market Size by Application (2019-2025) (Million US$)
Figure Global Active Pharmaceutical Ingredient (API) Market Size by Application (2019-2025)
Figure Global Active Pharmaceutical Ingredient (API) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources